Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with ...
We recently published 10 Firms Shining Bright in a Bleeding Market. Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the best-performing stocks on Monday. Jazz Pharmaceuticals soared to a new 52-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback